Emerging Infectious Diseases (Aug 2013)

Comparison of 2 Assays for Diagnosing Rotavirus and Evaluating Vaccine Effectiveness in Children with Gastroenteritis

  • Jacqueline E. Tate,
  • Slavica Mijatovic-Rustempasic,
  • Ka Ian Tam,
  • Freda C. Lyde,
  • Daniel C. Payne,
  • Peter Szilagyi,
  • Kathryn Edwards,
  • Mary Allen Staat,
  • Geoffrey A. Weinberg,
  • Caroline B. Hall,
  • James Chappell,
  • Monica McNeal,
  • Jon R. Gentsch,
  • Michael D. Bowen,
  • Umesh D. Parashar

DOI
https://doi.org/10.3201/eid1908.130461
Journal volume & issue
Vol. 19, no. 8
pp. 1245 – 1252

Abstract

Read online

We compared rotavirus detection rates in children with acute gastroenteritis (AGE) and in healthy controls using enzyme immunoassays (EIAs) and semiquantitative real-time reverse transcription PCR (qRT-PCR). We calculated rotavirus vaccine effectiveness using different laboratory-based case definitions to determine which best identified the proportion of disease that was vaccine preventable. Of 648 AGE patients, 158 (24%) were EIA positive, and 157 were also qRT-PCR positive. An additional 65 (10%) were qRT-PCR positive but EIA negative. Of 500 healthy controls, 1 was EIA positive and 24 (5%) were qRT-PCR positive. Rotavirus vaccine was highly effective (84% [95% CI 71%–91%]) in EIA-positive children but offered no significant protection (14% [95% CI −105% to 64%]) in EIA-negative children for whom virus was detected by qRT-PCR alone. Children with rotavirus detected by qRT-PCR but not by EIA were not protected by vaccination, suggesting that rotavirus detected by qRT-PCR alone might not be causally associated with AGE in all patients.

Keywords